Belgium· BE-AMP-SAM551724-00

Nobiten 5 mg

A nebivolol product containing nebivolol hydrochloride, registered in Belgium by PI Pharma. The same ATC class is registered in 16 of our 19 countries.

ATC C07AB12

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about nebivolol hydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Nebivolol is registered in 16 of 19 countries.

Countries holding a registration under ATC C07AB12 (nebivolol), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
10 of them publish a price we can compare per daily dose

Search nebivolol products by name

Nebivolol · ATC C07AB12

16 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Spainprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of nebivolol costs, country by country.

Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.092 in United States to $0.39 in Switzerland — a ×4.2 gap.

5 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Nebivolol · price per daily dose (5 mg)

USD · FX 28 Sept 2026

CH Switzerland$0.39
ES Spain$0.32
IT Italy$0.25
FR France$0.14
US United States$0.092 (acquisition cost)

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Nebivolol Hydrochloride
Manufacturer: PI Pharma
Country: Belgium (BE)
ATC code: C07AB12
ATC class: Nebivolol
Defined daily dose: 5 mg, O
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 3

2 priced

be_apb
2804466
EUR 18.83
be_apb
2630903
EUR 15.89
be_apb
0791723

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

273 interactions on record for nebivolol.

Graded by severity as the source publishes them — 10 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check nebivolol against other medicines How interaction checks work

Nebivolol · interactions on record

273 records

10 severe
202 moderate
17 minor

Most severe, free to view

DolasetronA04AA04severe
TheophyllinC01EB28severe
CeritinibL01ED02severe
CeritinibL01XE28severe

44 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Nebivolol in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All nebivolol products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

Austria · Nebilan, Nebivolol +pharma
Bulgaria · Nebilan, Nebivolol Sandoz
Cyprus · Lobivon, Nebivolol Accord
Czechia · Nebilet, Nebivolol Medreg
Germany · Nebilet, Nebivolol 089pharm
Denmark · Hypoloc, Nebivolol Accord
Estonia · Nebicard, Nebilet
Spain · Insucor, Lobivon
Finland · Hypoloc, Nebivolol Accord
France · Nebilox, Nebivolol Almus
United Kingdom (Northern Ireland) · Nebilet, Nebivolol
Greece · Bivol, Hypoloc
Croatia · Massido, Nebilet
Hungary · Nebibeta, Nebilet
Ireland · Nebilet, Nebimel
Italy · Lobivon, Nebilox
Lithuania · Nebicard, Nebilet
Luxembourg · Nebivolol Eg, Nobiten
Latvia · Nebilet, Nebivolol Actavis
Malta · Nebilet, Nebivolol Atb
Netherlands · Hypoloc, Lobivon
Poland · Daneb, Ebivol
Portugal · Nebilet, Nebivolol Aurovitas
Romania · Nebilet, Nebivolol Gemax Pharma
Slovenia · Nebilet, Nebivolol Krka
Slovakia · Nebilet, Nebitrix

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/aa5f9f74-c2c5-499a-97b8-f0bed32a597a
GET /v1/drugs/aa5f9f74-c2c5-499a-97b8-f0bed32a597a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Nobiten 5 mg",
  "name_fr": "Nobiten 5 mg",
  "name_nl": "Nobiten 5 mg",
  "amp_code": "SAM551724-00",
  "strengths": [
    "5.4500",
    "5.0000"
  ],
  "pack_count": 9,
  "substances": [
    "Nebivolol Hydrochloride",
    "Nebivolol",
    "Lactose Monohydrate",
    "Polysorbate 80"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Nebivolol",
  "authorisation_numbers": [
    "1637PI0513F003"
  ]
}

API reference MCP server Plans

See everything about nebivolol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console